Pharmaceutical - Markets & Marketing

Filter

Current filters:

Markets & Marketing

Popular Filters

1 to 25 of 1104 results

Merck's entry into allergic rhinitis market will send total market value soaring by 2018, says GlobalData

Merck's entry into allergic rhinitis market will send total market value soaring by 2018, says GlobalData

30-09-2014

The US market for treatments of allergic rhinitis is set to see its value increase fourfold by 2018,…

GlobalDataGrastekMarkets & MarketingMerck & CoOralairPharmaceuticalRagwitekRespiratory and PulmonarySingulairUSA

Intas launches DoceAqualip in India

30-09-2014

Indian drugmaker Intas Pharmaceuticals says it has successfully launched the world’s first DoceAqualip…

DoceAqualipdocetaxelIndiaIntas PharmaceuticalsMarkets & MarketingOncologyPharmaceutical

Achillion a good candidate for collaboration or takeover based on hepatitis C candidate, says Edison

Achillion a good candidate for collaboration or takeover based on hepatitis C candidate, says Edison

29-09-2014

Achillion Pharmaceuticals is in a prime position to develop its own all-oral hepatitis C treatment as…

Achillion PharmaceuticalsFinancialMarkets & MarketingNephrology and HepatologyPharmaceuticalUSA

Bayer’s Jadelle to be listed in New Zealand

Bayer’s Jadelle to be listed in New Zealand

26-09-2014

New Zealand’s Pharmaceutical Management Agency PHARMAC has announced the approval of an agreement with…

BayerJadelleMarkets & MarketingNew ZealandPharmaceuticalPricingReproductiveWomen's Health

Japan’s non-Hodgkin lymphoma market to exceed $1 billion by 2020

Japan’s non-Hodgkin lymphoma market to exceed $1 billion by 2020

26-09-2014

The non-Hodgkin lymphoma (NHL) treatment market in the Asia-Pacific (APAC) countries of India, Australia,…

AdcetrisAustraliaChinaGazyvaroIndiaJapanMarkets & MarketingOncologyPharmaceuticalRocheTakeda Pharmaceutical

EFPIA affirms strengthened commitment of industry in China with successful Beijing visit

EFPIA affirms strengthened commitment of industry in China with successful Beijing visit

26-09-2014

Trade group the European Federation of Pharmaceutical Industries and Associations (EFPIA) claims that…

ChinaEuropeHealthcareMarkets & MarketingPharmaceuticalPolitics

GlaxoSmithKline’s $490 million fine to spark pharma strategy shift in emerging markets, says analyst

GlaxoSmithKline’s $490 million fine to spark pharma strategy shift in emerging markets, says analyst

25-09-2014

UK pharma giant GlaxoSmithKline’s involvement in a large-scale bribery scandal in China came to an…

BrazilChinaGlaxoSmithKlineIndiaManagementMarkets & MarketingPharmaceutical

Brand India Pharma aims to make the most of a booming domestic pharma industry

Brand India Pharma aims to make the most of a booming domestic pharma industry

24-09-2014

India’s pharma exports stood at 90,000 crore rupees ($15 billion) for the year 2013-2014, and are set…

Brand India PharmaEconomy of IndiaHealth in the People's Republic of ChinaIndiaIndia Brand Equity FoundationMarkets & MarketingPharmaceutical

Decline in sales rep access makes digital communications vital, says ZS report

Decline in sales rep access makes digital communications vital, says ZS report

24-09-2014

Digital communication channels are becoming increasingly important as cost pressures mean drug reps reduce…

BusinessMarkets & MarketingPharmaceuticalResearchUnited StatesUSA

Despite limited size, Chile's pharma market offers growing opportunity

23-09-2014

By the end of 2014, the Chilean pharmaceutical market is expected to be worth $2 billion, increasing…

ChileHealthcareMarkets & MarketingPatentsPharmaceuticalRegulation

Russian government mulling restrictions of foreigners in state drug tenders

Russian government mulling restrictions of foreigners in state drug tenders

23-09-2014

The Russian government may take a decision about the imposition of restrictions on the participation…

AsiaMarkets & MarketingPharmaceuticalPoliticsRussia

EyeForPharma Multichannel Marketing Summit 2014:

EyeForPharma Multichannel Marketing Summit 2014: "Your desk is the worst place from which to view the world"

19-09-2014

One of the key messages from the EyeForPharma Multichannel Marketing Summit in London yesterday was that…

Health Medical PharmaLEO PharmaMarkets & MarketingPharmaceuticalPharmacologySanofiUK

Spain's pharma community has made necessary adjustments in recession, says PharmaBoardroom report

Spain's pharma community has made necessary adjustments in recession, says PharmaBoardroom report

19-09-2014

The Spanish pharma community has remained pragmatic throughout the European recession, says PharmaBoardroom’s…

Health Medical PharmaLife Sciences ReviewMarkets & MarketingPharmaceuticalSpain

EyeForPharma Multichannel Marketing Summit 2014: Lundbeck's Tim White on customer interaction, apps and buzzwords

EyeForPharma Multichannel Marketing Summit 2014: Lundbeck's Tim White on customer interaction, apps and buzzwords

19-09-2014

Tim White is head of global customer interaction at Lundbeck. The Pharma Letter spoke to him at the EyeForPharma…

DenmarkInterviewsLundbeckMarkets & MarketingNeurologicalPharmaceutical

First domestic-made erectile dysfunction drug debuts in China

19-09-2014

A Chinese pharmaceutical company on Thursday launched the country's first domestic-made erectile dysfunction…

Bai Yun Shan PharmaceuticalChinaJingeMarkets & MarketingMen's HealthPharmaceutical

Political developments impacting medicines for Russia

Political developments impacting medicines for Russia

17-09-2014

Russia's pharmaceutical market has been growing faster over recent years. The Pharma 2020 Strategy provides…

Markets & MarketingPharmaceuticalPoliticsRussia

Rheumatoid arthritis drug market will grow to $18.2 billion in 2023, report

17-09-2014

The rheumatoid arthritis (RA) disease-modifying antirheumatic drug market will increase from $14 billion…

Anti-Arthritics/RheumaticsbaricitinibBiosimilarsEli LillyEuropeIncyteJapanMarkets & MarketingPfizerPharmaceuticalUSAVertexXeljanz

Lundbeck launches Brintellix in Denmark

Lundbeck launches Brintellix in Denmark

16-09-2014

Danish CNS drug specialist Lundbeck is debutting its new antidepressant Brintellix (vortioxetine) in…

BrintellixCNS DiseasesDenmarkLundbeckMarkets & MarketingPharmaceutical

EFPIA wants to put an end to the resale of stolen and counterfeit drugs

EFPIA wants to put an end to the resale of stolen and counterfeit drugs

15-09-2014

The pan-European medicines verification system that the European Federation of Pharmaceutical Industries…

EuropeLegitimate supply chainMarkets & MarketingPharmaceuticalRegulation

Russia does not plan to ban drug imports from Western countries

12-09-2014

The Russian government has no plans to impose a ban on the pharmaceutical imports from the European Union…

Markets & MarketingPharmaceuticalPoliticsRussia

Latuda’s arrival better late than never for schizophrenia treatment in the UK, says analyst

12-09-2014

The recent introduction of antipsychotic drug Latuda (lurasidone) into the UK market, three years after…

Dainippon Sumitomo PharmaHealthcareLatudaMarkets & MarketingNeurologicalPharmaceuticalSunovion PharmaceuticalsUK

Ukraine takes measures to solve problem of drug shortages

12-09-2014

Ukraine is experiencing a shortage of pharmaceutical products, as the country’s government does not…

HealthcareMarkets & MarketingPharmaceuticalUkraine

1 to 25 of 1104 results

Back to top